Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma and anaplastic glioma

Por Lee, Eudocia Q., Reardon, David A., Schiff, David, Drappatz, Jan, Muzikansky, Alona, Grimm, Sean A., Norden, Andrew D., Nayak, Lakshmi, Beroukhim, Rameen, Rinne, Mikael L., Chi, Andrew S., Batchelor, Tracy T., Hempfling, Kelly, McCluskey, Christine, Smith, Katrina H., Gaffey, Sarah C., Wrigley, Brendan, Ligon, Keith L., Raizer, Jeffrey J., Wen, Patrick Y.
Publicado no Neuro Oncol (2015)

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy

Por Lee, Eudocia Q., Muzikansky, Alona, Drappatz, Jan, Kesari, Santosh, Wong, Eric T., Fadul, Camilo E., Reardon, David A., Norden, Andrew D., Nayak, Lakshmi, Rinne, Mikael L., Alexander, Brian M., Arvold, Nils D., Doherty, Lisa, Stefanik, Jennifer, LaFrankie, Debra, Ruland, Sandra F., Pulverenti, Julee, Smith, Katrina H., Gaffey, Sarah C., Hammond, Samantha, Wen, Patrick Y.
Publicado no Neuro Oncol (2016)

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma

Por Norden, Andrew D., Ligon, Keith L., Hammond, Samantha N., Muzikansky, Alona, Reardon, David A., Kaley, Thomas J., Batchelor, Tracy T., Plotkin, Scott R., Raizer, Jeffrey J., Wong, Eric T., Drappatz, Jan, Lesser, Glenn J., Haidar, Sam, Beroukhim, Rameen, Lee, Eudocia Q., Doherty, Lisa, Lafrankie, Debra, Gaffey, Sarah C., Gerard, Mary, Smith, Katrina H., McCluskey, Christine, Phuphanich, Surasak, Wen, Patrick Y.
Publicado no Neurology (2015)

Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma

Por Cloughesy, Timothy F., Mochizuki, Aaron Y., Orpilla, Joey R., Hugo, Willy, Lee, Alexander H., Davidson, Tom B., Wang, Anthony C., Ellingson, Benjamin M., Rytlewski, Julie A., Sanders, Catherine M., Kawaguchi, Eric S., Du, Lin, Li, Gang, Yong, William H., Gaffey, Sarah C., Cohen, Adam L., Mellinghoff, Ingo K., Lee, Eudocia Q., Reardon, David A., O’Brien, Barbara J., Butowski, Nicholas A., Nghiemphu, Phioanh L., Clarke, Jennifer L., Arrillaga-Romany, Isabel C., Colman, Howard, Kaley, Thomas J., de Groot, John F., Liau, Linda M., Wen, Patrick Y., Prins, Robert M.
Publicado no Nat Med (2019)

Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial

Por Wen, Patrick Y., Touat, Mehdi, Alexander, Brian M., Mellinghoff, Ingo K., Ramkissoon, Shakti, McCluskey, Christine S., Pelton, Kristine, Haidar, Sam, Basu, Sankha S., Gaffey, Sarah C., Brown, Loreal E., Martinez-Ledesma, Juan Emmanuel, Wu, Shaofang, Kim, Jungwoo, Wei, Wei, Park, Mi-Ae, Huse, Jason T., Kuhn, John G., Rinne, Mikael L., Colman, Howard, Agar, Nathalie Y.R., Omuro, Antonio M., DeAngelis, Lisa M., Gilbert, Mark R., de Groot, John F., Cloughesy, Timothy F., Chi, Andrew S., Roberts, Thomas M., Zhao, Jean J., Lee, Eudocia Q., Nayak, Lakshmi, Heath, James R., Horky, Laura L., Batchelor, Tracy T., Beroukhim, Rameen, Chang, Susan M., Ligon, Azra H., Dunn, Ian F., Koul, Dimpy, Young, Geoffrey S., Prados, Michael D., Reardon, David A., Yung, W.K. Alfred, Ligon, Keith L.
Publicado no J Clin Oncol (2019)